These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16878620)

  • 21. [Treatment with hydroxymethylglutaryl coenzyme-A-reductase inhibitors in elderly patients: is it necessary?].
    Alexa ID; Panaghiu L; Ungureanu G
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):721-6. PubMed ID: 16610166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guideline for management of lipid metabolism].
    Ishibashi S
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():675-8. PubMed ID: 12387068
    [No Abstract]   [Full Text] [Related]  

  • 23. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations.
    Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212
    [No Abstract]   [Full Text] [Related]  

  • 24. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets.
    Toth PP; Grabner M; Punekar RS; Quimbo RA; Cziraky MJ; Jacobson TA
    Atherosclerosis; 2014 Aug; 235(2):585-91. PubMed ID: 24956532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reasons for a combination].
    Núñez-Cortés JM
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():40-1. PubMed ID: 25043547
    [No Abstract]   [Full Text] [Related]  

  • 27. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
    Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
    Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
    Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D;
    Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
    Jialal I; Smith G
    Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
    [No Abstract]   [Full Text] [Related]  

  • 30. [Correction of antioxidative state during statin therapy of coronary heart disease with dyslipidemia].
    Artamoshina NE; Belaia OL; Radzevich AE; Kuropteva ZV; Baĭder LM
    Klin Med (Mosk); 2009; 87(11):25-9. PubMed ID: 20143561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic interactions of multidrug therapy for dyslipidemia.
    Mehta N; deGoma EM
    Curr Atheroscler Rep; 2013 Feb; 15(2):303. PubMed ID: 23299643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrates: where are we now?
    Seth Loomba R; Arora R
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):91-6. PubMed ID: 19144670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on lipids and C-reactive protein in acute and chronic coronary heart disease.
    Jones PH
    Tex Heart Inst J; 2010; 37(3):307-8. PubMed ID: 20548807
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.
    Athyros VG; Kakafika AI; Karagiannis A; Mikhailidis DP
    Am J Cardiol; 2008 Jun; 101(11):1679-80. PubMed ID: 18489951
    [No Abstract]   [Full Text] [Related]  

  • 35. Madelung's disease.
    Yeh NC; Yang CY; Chou CW; Yen FC; Lee SY; Tien KJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3012-3. PubMed ID: 22701018
    [No Abstract]   [Full Text] [Related]  

  • 36. From the editor: drugs, genes, and lipoproteins.
    Brown WV
    J Clin Lipidol; 2014; 8(6):529-530. PubMed ID: 25499933
    [No Abstract]   [Full Text] [Related]  

  • 37. Statins, cholesterol, and the prevention of coronary heart disease.
    Freeman MW
    FASEB J; 2006 Feb; 20(2):200-1. PubMed ID: 16449790
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical- and cost-effectiveness of LDL particle-guided statin therapy: a simulation study.
    Folse HJ; Goswami D; Rengarajan B; Budoff M; Kahn R
    Atherosclerosis; 2014 Sep; 236(1):154-61. PubMed ID: 25050538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of simvastatin in elderly patients with type 2 diabetes].
    Gonokhova LG
    Kardiologiia; 2006; 46(8):29-32. PubMed ID: 17058344
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipid pharmacotherapy for treatment of atherosclerosis.
    Nicholls SJ; Pisaniello AD; Kataoka Y; Puri R
    Expert Opin Pharmacother; 2014 Jun; 15(8):1119-25. PubMed ID: 24702590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.